Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-12-27 5:02 pm Sale | 13D | POINT BIOPHARMA GLOBAL INC PNT | SILBER ALLAN C | 0 0% | -9,316,184 (Position Closed) | View |
| 2023-10-03 2:57 pm Purchase | 13D | POINT BIOPHARMA GLOBAL INC PNT | SILBER ALLAN C | 9,316,184 8.8% | 84,816 (+0.92%) | View |
| 2023-03-20 06:13 am Sale | 13D | HERITAGE GLOBAL INC. HGBL | SILBER ALLAN C | 1,810,913 4.9% | -469,149 (-20.58%) | View |
| 2022-11-22 4:21 pm Purchase | 13D | POINT BIOPHARMA GLOBAL INC PNT | SILBER ALLAN C | 9,231,368 8.74% | 365,580 (+4.12%) | View |
| 2022-06-09 06:07 am Sale | 13D | HERITAGE GLOBAL INC. HGBL | SILBER ALLAN C | 2,280,062 6.22% | -1,332,803 (-36.89%) | View |
| 2021-09-14 3:11 pm Sale | 13D | HERITAGE GLOBAL INC. HGBL | SILBER ALLAN C | 3,612,865 9.96% | -372,407 (-9.34%) | View |
| 2021-07-12 4:37 pm Purchase | 13D | POINT BIOPHARMA GLOBAL INC PNT | SILBER ALLAN C | 8,865,788 9.8% | 8,865,788 (New Position) | View |
| 2021-05-12 11:01 am Sale | 13D | HERITAGE GLOBAL INC. HGBL | SILBER ALLAN C | 3,985,272 11.2% | -678,373 (-14.55%) | View |